JAMAL JOUDEH MD NPI 1922214352

NPI Information

  • NPI: 1922214352
  • Provider Name: JAMAL JOUDEH, MD
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 4724 N DAVIS HWY
    PENSACOLA, FL
    ZIP 32503
  • Phone: (850) 696-4000

Map and Directions

Get Directions

NPI Details

Jamal Joudeh, MD is a hematology and oncology internal medicine in Pensacola, FL with 25 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Jamal Joudeh, MD NPI is 1922214352. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

4724 N DAVIS HWY
PENSACOLA, FL
ZIP 32503-339
Phone: (850) 696-4000
Fax: (850) 435-9608

The NPI 1922214352 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS:Q5101)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, azacitidine, 1 mg (HCPCS:J9025)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
  • Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Injection, pegfilgrastim-bmez, biosimilar, (ziextenzo), 0.5 mg (HCPCS:Q5120)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Injection, gadobenate dimeglumine (multihance), per ml (HCPCS:A9577)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) (HCPCS:G0279)
  • Screening mammography (HCPCS:77067)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Screening 3d breast mammography (HCPCS:77063)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Blood creatinine level (HCPCS:82565)
  • Diagnostic mammography of both breasts (HCPCS:77066)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Nuclear medicine study whole body with ct scan (HCPCS:78816)
  • Mri scan of brain before and after contrast (HCPCS:70553)
  • Limited ultrasound scan of 1 breast (HCPCS:76642)
  • Complete ultrasound scan of 1 breast (HCPCS:76641)
  • Diagnostic mammography of 1 breast (HCPCS:77065)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Ultrasound study of one arm or leg veins with compression and maneuvers (HCPCS:93971)
  • Complete ultrasound scan of abdomen (HCPCS:76700)

The enumeration date for this NPI number is 5/15/2007 and was last updated on 5/6/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207R00000XInternal MedicineME112975FLORIDANo
2207RH0003XInternal MedicineHematology & OncologyME112975FLORIDAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
17267946OTHERFLORIDAAETNA
214K7WOTHERFLORIDABCBS
31178638OTHERFLORIDAWELLCARE
4GC718YOTHERFLORIDAMEDICARE
5MT183299OTHERPENNSYLVANIAGRADUATE MEDICAL TRAINEE
6GC718YMEDICARE PINFLORIDA
7P01428446OTHERFLORIDARR MEDICARE
87920283OTHERFLORIDACIGNA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.